A Special Report

Revealed: The Motley Fool’s Top 3 Dividend Shares for 2020

Revealed:
The Motley Fool’s Top Dividend Stock for 2020 (and 2 bonus picks)

Thanks for taking the time to access my report. My name’s Edward Vesely and I’m the lead advisor of one of Australia’s most popular stock picking services, Motley Fool Dividend Investor.

Very soon you’ll receive your first issue of Take Stock. It’s full of vital information and investment ideas that I believe will help you grow, and when necessary, protect your wealth. I recommend you give it a good read. It’ll only take you a few minutes to read each issue, but it could prove to drastically change your future.

In fact, I think there’s never been a more critical time to be getting unbiased, professional insight into the stock market and economy. Right now, as we all know, the Covid-19 crisis has seen share markets fall 30% or so in the space of a few weeks after a steady rise throughout 2019 and early 2020. Despite these across-the-board falls, investors can still be caught out owning the wrong shares at the wrong time, shares that fail to come back at all once the crisis passes.

The good news is, we’re confident there are still hidden gems out there that have the potential to hand you solid gains and income – even if the market continues to go south. But the question is, where do you find them?

That’s where I come in. Today, I’m going to reveal to you our top dividend play for 2020 (and beyond). As a thank you for being a loyal reader, we’ll also throw in two “bonus picks” (who we believe are also fantastic options for dividend investors) absolutely free. Each of these three companies boast fully franked yields and could be a great fit for your diversified portfolio.

Not only that, I’m also going to show you how you can access all of my other top dividend BUY recommendations inside my exclusive Motley Fool Dividend Investor service. If you’re looking for a wealth of NEW dividend investing ideas beyond the “usual suspects” like banks, Woolies and Wesfarmers, look no further.

But before I get to that, let’s review my top dividend share for the coming 12 months.

Our top dividend pick: #1: Bapcor (ASX: BAP)

Bapcor is primarily a trade-focused auto aftermarket parts business with operations in Australia, New Zealand and Thailand.

The company owns 184 trade stores around Australia, and another 72 across the Tasman, with plans to add between 10 and 12 more per annum over the next 5 years. Unlike most retailers,  however, these stores aren’t located on busy street corners; they’re conveniently located around nearby workshops, allowing them to quickly deliver the parts required by mechanics.

When a person’s car runs into maintenance issues, they don’t really have a choice: they have to get it repaired right away, which makes for steady business for Bapcor. Better yet, a recession can actually be seen as good news for Bapcor: as customers put off buying new cars, they must spend more on keeping the ones they own running.

In the trade business, Bapcor’s customer is the mechanic, not the end user (the driver). That gives Bapcor a lot of pricing power, and is one of the reasons it has managed to grow its same store sales at an average of 4% per annum over the past five years.

The remainder of Bapcor’s income comes from its retail (predominantly Autobarn) and specialist wholesale operations, which together accounted for 51% of revenue and 45% of earnings from continuing operations in the first half of FY 2020.

Bapcor is led by CEO Darryl Abotomey, who has pioneered the company’s growth since 2011 (and led its IPO in 2014). He has recently signed a new contract extending his tenure in the top job until April 2022, and has approximately $7 million of his own shares in the company to ensure his interests are aligned with our own.

Risks and When We’d Sell

We think Bapcor’s trade business is relatively protected from Amazon.com (NASDAQ: AMZN), due to its strong relationships with mechanics. But its retail network is susceptible, as well as to other competitors. This does have the potential to have an impact on Bapcor’s overall performance, given its retail segment accounts for around 19% of its revenue and 17% of its operating earnings.

Bapcor has done a tremendous job integrating acquisitions to date, but there is always a risk that won’t continue. An ill-timed acquisition, or simply paying too much, could be disastrous for the group.

The Foolish Bottom Line

Bapcor provides investors with resilient earnings, growth potential and a healthy dividend yield (3.6% fully franked, at the time of writing). It’s time to drive Bapcor into your portfolio.

Top dividend runner up #2: Sonic Healthcare (ASX:SHL)

Sonic Healthcare is a global medical diagnostics company that operates in a number of countries. including Australia, the USA, Germany, Switzerland, the United Kingdom, Belgium, Ireland and New Zealand.

It’s been able to demonstrate reliability in its growth profile and, as such, is now one of the largest operators in its field.

Sonic has been able to consistently grow its revenue, net profit and dividend over the last 25 years, allowing it, today, to present itself as a company with one of the best financial track records of any company on the ASX.

It started out locally in Australia and quickly scaled its pathology business here before the natural confines of a smaller market encouraged it to expand its operations globally.

These efforts were so successful that the proportion of Australian revenue now accounts for only 23% or so of the total.

But we believe there’s more to come. Management continues to see a strong pipeline of further acquisition opportunities within the US and, given its track record for high quality capital allocation, we remain enthusiastic that this will support further growth in the years ahead. As scale increases, the company places itself in a potentially better position relative to other competitors in the marketplace, further strengthening its competitive advantage.

Tailwinds supporting the company include ageing population in the countries it operates in, as well as the impetus for testing from the growing prevalence of Covid-19.

For instance, its US laboratories are now expanding testing capacity throughout its lab network in that country, ensuring availability to help mitigate high demand in certain regions. The current situation should see a real boost more generally for greater numbers of pathology tests and other viral-type infections across its whole network.

Risks and When We’d Sell

In the short term, there’s a chance that diagnostic testing volumes will be impacted as populations quarantine themselves due to the Covid-19 situation. If, however, this has a longer-term impact on testing capacity volume growth, or the impact of Covid-19 extends for a period much longer than expected, we may reconsider the recommendation in light of other potential ideas elsewhere in the market.

Another risk arises from potential changes to the regulatory environment in the countries it operates in. For example, any changes to the funding by governments could mean higher costs for the business and reduced margins. If such a situation was to be sustained, we’d be likely sellers of the company’s shares given pathology accounts for the vast bulk of Sonic’s revenues.

The Foolish Bottom Line

In an uncertain and highly volatile market it can sometimes pay to include quality global companies in your portfolio that operate in industries with minimal disruption from recession and/or other macroeconomic shocks. The company is well positioned to capitalise on an ageing population in the markets it operates in, supported by a greater awareness of the need for pathology brought about by the current crisis.

Top dividend runner up #3: PWR Holdings(ASX:PWH)

PWR Holdings (ASX:PWH) designs and manufactures cooling technologies for customers around the world operating in elite motorsport, as well as those which manufacture high-performance applications in the automotive industry. 

Its products include radiators, high-tech engine oil coolers, and battery-cooling technologies which are sold to customers that include 9 of the top 10 Formula One teams competing in the FIA Formula One World Championship. As well as this, it serves motor sport teams competing in the World Rally Championship, NASCAR, Le Mans, Indy Car, DTM Germany, Super GT Japan, Supercars Australia and a host of others. As a result, the company sources over 85% of its revenue from outside Australia.

PWR Holdings is a fast growing small cap stock, with a long growth runway, pays a growing fully franked dividend, and recently also declared a special dividend. 

Although its current dividend yield is relatively modest, due to its growth prospects, an investment in PWR Holdings offers the prospect of significant capital appreciation. 

As far as dividend shares go, because it’s a smaller company, this is a higher risk investment. That’s why we always recommend it forms part of a diversified portfolio of shares. 

It’s a founder-led company with a clean balance sheet. In February 2020  PWR Holdings reported for the FY20 half year revenue growth of 20%, and an increase in net profit after tax of 10%, which enabled it to increase its interim dividend by 19% (fully franked).

The company is actively pursuing research and development (R&D) into cooling systems for electronics and batteries — used particularly in autonomous and electric vehicles. PWR Holdings’ future, therefore, isn’t necessarily dependent on the internal combustion engine and is well positioned to serve a number of different transport technologies across both conventional petrol/diesel and electric engine-powered vehicles.

With its industry leading technology and a reputation for working closely with its customers to provide bespoke solutions, we see continued growth in its future.

Although the trailing yield today is only 2.6% (fully franked), — excluding the special dividend — the expected increases in revenue, profit and dividend — combined with the steady hand of Managing Director Kees Weel who owns 27% of the company — makes PWR Holdings an attractive investment at current prices.

Risks and when we’d sell

If the company was to see the loss of key customers, or customers simply ceasing their relationship with motorsport — whether caused by the current Covid-19 crisis or otherwise — then this could have an impact on the growth profile. If a significant number of key customers walked, then this could be a thesis-breaker for us.

Also for consideration is the risk of currency movements, especially given its exposure to the British pound and the US dollar. The company has a natural hedge with it operations in each of these countries, but you can expect there to be some effect on earnings each year as a result of currency movements due to Australian revenues accounting for only 15% of the total.

Finally, increased costs of the business beyond what’s been planned for could also affect the company. Most of the raw materials that PWR Holdings relies upon are imported from overseas suppliers, so any key price increase from suppliers could see margins shaved. Staff and labour costs are also the company’s biggest expense, so good relations with its staff are paramount. 

The Bottom Line

PWR Holdings is extremely well positioned competitively, and has strong relationships with many of its customers due to its reputation for reliability and quality production. With an expectation of insatiable demand for its key products and the prospects for solid earnings growth in the years ahead

The Recap

Just to recap our top dividend stock for 2020 is Bapcor (ASX:BAP) and our runners up, which could be fantastic options within a diversified portfolio are Sonic Healthcare (ASX:SHL) and PWR Holdings (PWH)

We hope these dividend shares help you on your way to becoming Smarter, Happier and Richer, with the first steps of well diversifield portfolio and a fantastic year ahead of investing.

To your dividend wealth,


Edward Vesely
Lead Advisor, Motley Fool Dividend Investor

As of 30 March 2020.

Ed Vesely owns shares of Bapcor. The Motley Fool Australia owns shares of Bapcor. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. For more information about The Motley Fool see our Financial Services Guide. All returns cited are hypothetical and based on the percentage change between the stock price at the time of recommendation and the current or sell price (if the position has been closed) at the time of publication. Brokerage, taxes and any other associated costs are not taken into account. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.

© Copyright The Motley Fool Australia Pty Ltd. 2010 – 2019. All rights reserved.